← Leaderboards
David Hout
Insight Genetics, Inc.
$3,388,847
Attributed
$3,388,847
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2010–13$2M$1.5M$1M$500K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$3,388,847 · 4
By mechanism
N44$2,995,210 · 2
N43$393,637 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Specimen”
- Jeffrey P Krischer · University Of South Florida$372,057,923
- Marian Ewell · The Emmes Company, Llc$278,931,253
- David Heimbrook · Leidos Biomedical Research, Inc.$273,257,812
- James Dennis Neaton · Northwestern University$273,164,823
- Judith S. Currier · University Of California Los Angeles$170,089,509
- Barbara Driver · Westat, Inc.$161,528,142
Research focus
SpecimenPharmacologic SubstanceDiagnosticMutationInhibitor/AntagonistInsightGeneticValidationCompanionsCancer Cell LineMalignant NeoplasmsTumorCohortPre-ClinicalProgramsCell LinePhosphotransferasesReportingKinase InhibitorDetectionDesignCancer TherapyMalignant Neoplasm Of LungCancer Patient
Grant awards (4)
Development of a Clincial Diagnostic Assay for ALK Inhibitor Mutations$1,499,990
N44 · FY2013 · CA · contact PI
OTHER FUNCTIONS DEVELOPMENT OF A COMPANION DIAGNOSTIC FOR ALK MUTATIONS.$1,495,220
N44 · FY2012 · CA · contact PI
TAS::75 0849::TAS SBIR TOPIC 277 - DEVELOPMENT OF A CLINICAL DIAGNOSTIC ASSAY FO$193,637
N43 · FY2011 · CA · contact PI
Companion Diagnostic for ALK Mutations$200,000
N43 · FY2010 · CA · contact PI